Abstract
This study compared an Aeron office chair and a commercial gaming chair (GC) on muscle stiffness (MS), performance, and perceptions during a 2-hour gaming session.
Thirty-three esports players (23 ± 4.9) signed consent to participate in this mixed-methods randomized study. Subjects played League of Legends (LoL) in a controlled environment for two 2-hour sessions. MS was measured using oscillation frequency. Investigators recorded evaluations, game statistics, and player perceptions.
Descriptive statistics showed lower MS in the thoracic and lumbar region (left -4.4% vs. 0.32%; -2.7% vs. -2.1%; right 0.2% vs. 8.3%; 7% vs. 10.8%). The upper shoulder was higher in the GC only on the right (9.2% vs. -6.4; left 4.7 vs. 7.5). Most participants preferred the GC (58%), and players won 25% more and achieved 15% more kills in the GC.
The GC exhibited lower levels of muscle stiffness in the thoracic and lumbar regions. This data suggests that the GC is the preferred choice among this group of LoL gamers and is associated with enhanced performance.
Competing Interest Statement
I have read the journal's policy and the authors of this manuscript have the following competing interests: This project received funding from Secret Lab Inc.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the New York Institute of Technology (NYIT) Institutional Review Board (BHS-1790). All subjects signed written informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data are available by request for researchers who meet the criteria for access to confidential data.
